Cadila Healthcare has given breakout from its Inverse H&S and is sustaining the move.
BUY for target of Rs500-550, which is 25 to 40% upside from current levels.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
